Surmodics | SRDX - Операционный доход





Операционный доход Изменить Дата
Abbott USD 1.85B 399M 2026-03
Align Technology USD 178.05M 46.66M 2026-03
Anika Therapeutics USD 646K 3.88M 2025-12
Arrowhead Research USD 40.81M 3.3M 2025-12
Artivion USD 4.79M 6.85M 2025-12
Baxter International USD 66M 280.2M 2026-03
Boston Scientific USD 1.05B 190M 2026-03
EDAP TMS EUR -4.92M 843K 2025-09
Edwards Lifesciences USD 514.7M 144.4M 2026-03
Haemonetics USD 67.4M 8.9M 2025-12
Heron Therapeutics USD 38K 3.83M 2025-12
J&J USD 6.62B 1.03B 2026-03
Merit Medical Systems USD 44.16M 10.04M 2026-03
Mesa Laboratories USD 5.78M 2.27M 2024-12
Nektar Therapeutics USD -19.09M 15.26M 2025-12
Option Care Health USD 72.54M 18.96M 2026-03
Stryker USD 1.1B 867M 2026-03
Surmodics USD 58K 5.7M 2025-06
Trinity Biotech USD -509K 6.27M 2025-09